Skip to content
Inciteful Med
Resources About us Ask a Question

How Long Does Botox for Gastroparesis Last?

Published: | Updated:

Botox injections for gastroparesis typically provide temporary relief that lasts for several months before wearing off. Doctors often use this short-term symptom reduction as a diagnostic trial to predict if permanent surgical procedures like G-POEM will be successful for the patient.

Key Takeaways

  • • Botox injections provide temporary relief from gastroparesis symptoms, typically lasting for a few months.
  • • The procedure relaxes the pyloric valve, allowing food to empty from the stomach more easily.
  • • Doctors frequently use Botox as a diagnostic trial to see if your symptoms respond to pyloric relaxation.
  • • A successful Botox trial strongly suggests that permanent procedures like G-POEM or pyloroplasty will be effective.
  • • Even if a Botox injection provides only partial relief, you may still be a candidate for long-term surgical options.

Botulinum toxin (Botox) injections into the pyloric valve typically provide temporary relief from gastroparesis symptoms, with effects that reliably wear off over several months [1][2][3]. Because the medication is eventually broken down and cleared by the body, it is not a permanent cure for delayed stomach emptying [4][5].

How Botox Relieves Symptoms

The pyloric valve (or pylorus) is the muscular ring at the bottom of the stomach that opens to let food pass into the small intestine. In many people with gastroparesis, this muscle spasms or fails to relax properly, trapping food in the stomach. Injecting Botox directly into this muscle temporarily paralyzes and relaxes it, allowing food to empty more easily and potentially reducing severe daily symptoms like nausea, vomiting, and feeling full after just a few bites.

While some patients may notice an improvement in their ability to tolerate food within a week or two, the relief typically lasts for a few months before the muscle tightens up again [6][2].

What to Expect During the Procedure

If your doctor recommends a Botox trial, it is usually administered during an upper endoscopy. While you are under sedation, a doctor inserts a flexible tube with a camera down your throat and into your stomach to inject the Botox directly into the pyloric muscle [6][7].

Because it is an endoscopic procedure, there are no surgical incisions. However, there are still potential risks. Common side effects can include temporary worsening of nausea or sore throat from the endoscopy. More rarely, there are risks of bleeding at the injection site or systemic reactions to the toxin itself, such as severe weakness (botulism) [8].

Why It Is Used as a Temporary Test

Because the clinical results of Botox can vary greatly, doctors often use it as a diagnostic trial therapy rather than a definitive treatment [9][10][11]. Since the effects are temporary, it allows you and your doctor to observe how well your symptoms respond to a relaxed pylorus before committing to a permanent, non-reversible surgery [9][10][11]. In this context, it serves as an excellent diagnostic tool to predict if permanent procedures like G-POEM (Gastric Per-Oral Endoscopic Myotomy) or a surgical pyloroplasty will be successful.

Transitioning to Long-Term Treatments

While Botox provides a temporary, reversible chemical relaxation, procedures like G-POEM permanently cut and relax the stomach muscle [12][10][13].

If you experience noticeable relief from nausea and vomiting during the months that the Botox is active, it strongly suggests that your symptoms are directly related to a tight pyloric valve. This information helps your medical team confidently recommend a permanent procedure like G-POEM, which has demonstrated superior durability and long-term effectiveness compared to repeated Botox injections [14][10][15].

Importantly, even if a Botox trial does not provide complete relief, some patients may still benefit from G-POEM or other therapies. Permanent procedures physically alter the muscle in a way that chemical injections cannot [10][16][17]. Your care team may use additional diagnostic tools, such as the EndoFLIP (Endoscopic Functional Luminal Imaging Probe)—a balloon-like device that objectively measures the pressure and stretch of your pylorus—to further evaluate if a permanent procedure is right for you [18][19].

Frequently Asked Questions

How long do the effects of Botox for gastroparesis last?
Botox injections provide temporary relief from gastroparesis symptoms that typically lasts for a few months. Because the body eventually breaks down and clears the medication, it is not a permanent cure for delayed stomach emptying.
How is the Botox administered for delayed stomach emptying?
Botox is injected directly into the pyloric valve during an upper endoscopy. While you are under sedation, a doctor uses a flexible tube with a camera to deliver the medication into the muscle without making any surgical incisions.
Why do doctors use Botox as a trial therapy instead of a cure?
Since the effects eventually wear off, Botox serves as an excellent temporary test to see if relaxing your pyloric valve relieves your symptoms. A successful trial can help your care team confidently recommend permanent procedures like G-POEM.
If Botox only provides partial relief, does that mean permanent surgery won't work?
Not necessarily. Even if a Botox trial does not completely relieve your nausea and vomiting, permanent procedures physically alter the muscle differently than chemical injections. You may still benefit from long-term surgical options based on other diagnostic tests.
What are the potential side effects of a stomach Botox injection?
Common side effects include a sore throat from the endoscopy procedure or a temporary worsening of nausea. More rarely, there are risks of bleeding at the injection site or severe systemic reactions like botulism weakness.

Questions for Your Doctor

  • • What specific daily symptoms should I track to determine if the Botox trial is a success?
  • • How long will we wait after the Botox injection before deciding whether to move forward with a permanent procedure like G-POEM?
  • • Am I a candidate for diagnostic tests like EndoFLIP to measure my pyloric valve function?
  • • If the Botox trial only provides partial relief, does that mean I am not a good candidate for permanent surgical options?
  • • What are the specific risks I should watch out for in the days following the Botox injection?

Questions for You

  • • Do I struggle most with severe nausea and vomiting, or is my primary issue abdominal pain and bloating?
  • • How severely does my inability to empty my stomach impact my ability to eat, hydrate, and maintain my weight?
  • • Have I kept a symptom journal to accurately track if interventions like diet changes or medications have provided any real relief?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Intrapyloric botulinum toxin injection for functional nausea and vomiting: Just a placebo?

    Bolia R

    Neurogastroenterology and motility 2022; (34(12)):e14479 doi:10.1111/nmo.14479.

    PMID: 36194187
  2. 2

    Comparison of Symptom Control in Pediatric Gastroparesis Using Endoscopic Pyloric Botulinum Toxin Injection and Dilatation.

    Mercier C, Ley D, Aumar M, et al.

    Journal of pediatric gastroenterology and nutrition 2021; (73(3)):314-318 doi:10.1097/MPG.0000000000003195.

    PMID: 34091544
  3. 3

    Endoscopic ultrasonography-guided intrapyloric injection of botulinum toxin to treat diabetic gastroparesis.

    Yin G, Tan W, Hu D

    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 2016; (28(7)):759 doi:10.1111/den.12711.

    PMID: 27556873
  4. 4

    Intrapyloric Botulinum Toxin A Injection for Gastroparesis and Functional Upper Gastrointestinal Symptoms in Children: Mayo Clinic Experience, Review of the Literature, and Meta-analysis.

    Ezaizi Y, Hasan B, Manini ML, Absah I

    Paediatric drugs 2022; (24(5)):539-545 doi:10.1007/s40272-022-00518-x.

    PMID: 35768647
  5. 5

    Gastrointestinal Uses of Botulinum Toxin.

    Cariati M, Chiarello MM, Cannistra' M, et al.

    Handbook of experimental pharmacology 2021; (263()):185-226 doi:10.1007/164_2019_326.

    PMID: 32072269
  6. 6

    Botulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Experience.

    Lee JH, Kim CG, Kim YW, et al.

    Journal of gastric cancer 2017; (17(2)):173-179 doi:10.5230/jgc.2017.17.e18.

    PMID: 28680722
  7. 7

    Intra-pyloric botulinum toxin injection improves liquid gastric emptying using 99mTc DTPA scintigraphy: a case report in a 2 years- old girl with idiopathic gastroparesis.

    Sumitro KR, Darma A, Sucianti TP, et al.

    Asia Oceania journal of nuclear medicine & biology 2025; (13(2)):190-194 doi:10.22038/aojnmb.2025.84182.1599.

    PMID: 40585284
  8. 8

    Systemic Botulism Toxicity Caused by Pyloric Botox Injection to Treat Gastroparesis.

    Bensen GP, Rutherford CC, Gardner TB

    Case reports in gastroenterology 2020; (14(2)):373-376 doi:10.1159/000508854.

    PMID: 32884513
  9. 9

    Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and Treatment.

    Na HK, Li AA, Gottfried-Blackmore A, et al.

    Gut and liver 2025; (19(3)):327-345 doi:10.5009/gnl240421.

    PMID: 40058793
  10. 10

    Gastric peroral endoscopic myotomy versus botulinum toxin injection for the treatment of refractory gastroparesis: results of a double-blind randomized controlled study.

    Gonzalez JM, Mion F, Pioche M, et al.

    Endoscopy 2024; (56(5)):345-352 doi:10.1055/a-2235-3286.

    PMID: 38141620
  11. 11

    Per Oral Pyloromyotomy for Treatment of Gastroparesis in a Pediatric Patient.

    August AT, Landisch R, Hassan M, Wall JK

    JPGN reports 2021; (2(2)):e054 doi:10.1097/PG9.0000000000000054.

    PMID: 37207063
  12. 12

    Efficacy of gastric per-oral endoscopic myotomy remains similar after failure of interventional techniques in refractory gastroparesis.

    Chartier M, Duboc H, Moszkowicz D, et al.

    Clinics and research in hepatology and gastroenterology 2024; (48(9)):102481 doi:10.1016/j.clinre.2024.102481.

    PMID: 39426619
  13. 13

    Clinical efficacy of gastric per-oral endoscopic myotomy (G-POEM) in the treatment of refractory gastroparesis and predictors of outcomes: a systematic review and meta-analysis using surgical pyloroplasty as a comparator group.

    Mohan BP, Chandan S, Jha LK, et al.

    Surgical endoscopy 2020; (34(8)):3352-3367 doi:10.1007/s00464-019-07135-9.

    PMID: 31583465
  14. 14

    Redefining the Treatment Landscape in Gastroparesis: A Clinical Review of Gastric Peroral Endoscopic Myotomy Outcomes and Therapeutic Integration.

    Essilfie-Quaye K, Creamer C, Abuassi M, et al.

    DEN open 2026; (6(1)):e70260 doi:10.1002/deo2.70260.

    PMID: 41378163
  15. 15

    Gastric per-oral endoscopic myotomy versus pyloric injection of botulinum toxin for the treatment of gastroparesis: our institutional experience and a systematic review of the literature.

    Tran D, Leeds SG, Fair L, et al.

    Surgical endoscopy 2023; (37(9)):7280-7287 doi:10.1007/s00464-023-10262-z.

    PMID: 37430121
  16. 16

    Obstructive Gastroparesis: Patient Selection and Effect of Laparoscopic Pyloroplasty.

    Wellington J, Stuart P, Westcott C, Koch KL

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2020; (24(8)):1778-1784 doi:10.1007/s11605-019-04240-x.

    PMID: 31270719
  17. 17

    Peroral endoscopic pyloromyotomy accelerates gastric emptying in healthy pigs: proof of concept.

    Geyl S, Legros R, Charissou A, et al.

    Endoscopy international open 2016; (4(7)):E796-9 doi:10.1055/s-0042-108192.

    PMID: 27556100
  18. 18

    Significant changes in impedance planimetry (EndoFLIP™) measurements after peroral pyloromyotomy for delayed gastric emptying.

    Attaar M, Su B, Wong HJ, et al.

    Surgical endoscopy 2022; (36(2)):1536-1543 doi:10.1007/s00464-021-08441-x.

    PMID: 33742274
  19. 19

    Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function.

    Jacques J, Pagnon L, Hure F, et al.

    Endoscopy 2019; (51(1)):40-49 doi:10.1055/a-0628-6639.

    PMID: 29895073

This page provides educational information about Botox injections for gastroparesis and is not a substitute for professional medical advice. Always consult your gastroenterologist or care team to discuss diagnostic trials and specific treatment options.

Stay up to date

Get notified when new research about Gastroparesis is published.

No spam. Unsubscribe anytime.